Article Menu

Export Article

More by Authors Links

Article Data

  • Views 2712
  • Dowloads 163

Case Reports

Open Access

Uterine carcinosarcoma with chondrosarcoma component in a 60-year-old woman

  • F. Lai-Tiong1,*,

1,Medical Oncology unit

2 Institut de Cancérologie du Gard, Nîmes (France)

DOI: 10.12892/ejgo3684.2018 Vol.39,Issue 1,February 2018 pp.149-150

Published: 10 February 2018

*Corresponding Author(s): F. Lai-Tiong E-mail: florencelt@hotmail.fr

PDF (91.21 kB) View Full-text

Abstract

Carcinosarcoma of the uterus (malignant mixed Müllerian tumor: MMMT) is a rare and very aggressive form of uterine cancer. It represents about 3- 4% of uterine malignancy. This is a biphasic tumor that contains both carcinoma and sarcoma components. The author reports an original case of a carcinosarcoma of the uterus with heterologous sarcoma component in a 60 year-old Caucasian woman, revealed by gynecological bleeding. The patient underwent radical surgery with a large lymph node dissection (54 nodes) and peritoneal cytology. It was a pT3apN1, FIGO Stage III. It was decided to deliver adjuvant chemotherapy followed by radiotherapy.

Keywords

Uterine carcinosarcoma; Rare gynecological tumor; Gynecological bleeding; Chondrosarcoma; MMMT.

Cite and Share

F. Lai-tiong. Uterine carcinosarcoma with chondrosarcoma component in a 60-year-old woman. European Journal of Gynaecological Oncology. 2018; 39(1): 149-150. doi: 10.12892/ejgo3684.2018

URL:

https://www.ejgo.net/articles/10.12892/ejgo3684.2018

References

[1] Ahuja A., Safaya R., Prakash G., Kumar L., Shukla N.K.: “Primary mixed mullerian tumor of the vagina-a case report with review of the literature”. Pathol Res Pract., 2011, 207, 253.

[2] Garg G., Shah J.P., Kumar S., Bryant C.S., Munkarah A., Morris R.T.: “Ovarian and uterine carcinosarcomas: a comparative analysis of prognostic variables and survival outcomes”. Int. J. Gynecol. Cancer, 2010, 20, 888.

[3] Sutton G., Kauderer J., Carson L.F., Lentz S.S., Whitney C.W., Gallion H., Gynecologic Oncology Group.: “Adjuvant Ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study”. Gynecol. Oncol., 2005, 96, 630.

[4] Kuyumcuoglu U., Kale A.: “Homologous type of malignant mixed Mullerian tumor of the uterus presenting as a cervical mass”. J. Chin. Med. Assoc., 2009, 72, 533.

[5] Doss L.L., Llorens A.S., Henriquez E.M.: “Carcinosarcoma of the uterus: a 40-year experience from the state of Missouri”. Gynecol. Oncol., 1984, 18, 43.

[6] El-Nashar S.A., Mariani A.: “Uterine carcinosarcoma”. Clin. Obstet. Gynecol., 2011, 54, 292.

[7] Genever A.V., Abdi S.: “Can MRI predict the diagnosis of endometrial carcinosarcoma?” Clin. Radiol., 2011, 66, 621.

[8] Magnani K.K., Dubey S., Rai S.: “Malignant mixed Müllerian tumor of the uterus associated with tamoxifen therapy for breast cancer”. Indian J. Pathol. Microbiol., 2010, 53, 886.

Submission Turnaround Time

Top